Christopher Gibson, CEO: Recursion Pharmaceuticals RXRX Sell · Filed 25/10/24

Trade details

Type: Insider sale
Amount: $570,000
Shares · price: 100,000 sh · $5.70 a share
Held after: 954,229 sh
Stock: Recursion Pharmaceuticals RXRX
Person: Christopher GibsonCEO
Trade date: 25/10/23
Filed: 25/10/24
Days to filing: 1 days

Sold 9.5% of holdings

Share of holding sold: 9.5%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/09/23~25/11/22

Christopher Gibson's recent trades

Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$262K
77,290 sh
$262K
Filed 08/21
Traded 08/21
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$255K
75,000 sh
$255K
Filed 08/20
Traded 08/20
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$327.5K
100,000 sh
$327.5K
Filed 08/19
Traded 08/19
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$80.4K
26,806 sh
$80.4K
Filed 08/18
Traded 08/18
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$331K
100,000 sh
$331K
Filed 08/13
Traded 08/13